Cargando…
Glioblastoma: Current Status, Emerging Targets, and Recent Advances
[Image: see text] Glioblastoma (GBM) is a highly malignant brain tumor characterized by a heterogeneous population of genetically unstable and highly infiltrative cells that are resistant to chemotherapy. Although substantial efforts have been invested in the field of anti-GBM drug discovery in the...
Autores principales: | Thakur, Amandeep, Faujdar, Chetna, Sharma, Ram, Sharma, Sachin, Malik, Basant, Nepali, Kunal, Liou, Jing Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297300/ https://www.ncbi.nlm.nih.gov/pubmed/35786935 http://dx.doi.org/10.1021/acs.jmedchem.1c01946 |
Ejemplares similares
-
Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenal
por: Nepali, Kunal, et al.
Publicado: (2022) -
Recent developments in epigenetic cancer therapeutics: clinical advancement and emerging trends
por: Nepali, Kunal, et al.
Publicado: (2021) -
Flavone-based dual PARP-Tubulin inhibitor manifesting efficacy against endometrial cancer
por: Sharma, Sachin, et al.
Publicado: (2023) -
Current status and recent advances in reirradiation of glioblastoma
por: Minniti, Giuseppe, et al.
Publicado: (2021) -
Tumor microenvironment in glioblastoma: Current and emerging concepts
por: Sharma, Pratibha, et al.
Publicado: (2023)